Serina Therapeutics SER
NYSE SER
$2.00 -0.01 (-0.48%)
As of: Oct 1, 2026 · 3:14 PM EDT

Serina Therapeutics (SER) Total Non-Current Liabilities (2019 - 2025)

Updated

Serina Therapeutics' Total Non-Current Liabilities came in at $3.75 million for Q2 2025, down 72.6% from $13.69 million a year earlier but up 45.3% from the prior quarter.

Analysis

Serina Therapeutics (SER) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends

At the end of FY2024, Serina Therapeutics' Total Non-Current Liabilities was $2.63 million, down 93.6% from FY2023.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of -4.4% (FY2019 to FY2024).
  • Going back by year, Total Non-Current Liabilities was $41.26 million in FY2023 (+1.0%), $40.84 million in FY2022 (+355.4%), $8.97 million in FY2021 (+65.4%) and $5.42 million in FY2020 (+64.4%).
  • The five-year range for quarterly Total Non-Current Liabilities is $2.58 million (Q1 2025) to $48.3 million (Q1 2023).
  • Year-over-year, Total Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 63.4% over the last five quarters.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q1 2023 (growth of 378.3%), and the weakest in Q4 2024 (a decline of 93.6%).
  • Business Quant data shows SER's Total Non-Current Liabilities at $2.58 million (Q1 2025), $2.63 million (Q4 2024) and $14.52 million (Q3 2024) in the three quarters before Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Serina Therapeutics 32.93 Mn -7.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.75 Mn
Mar 31, 2025 2.58 Mn
Dec 31, 2024 2.63 Mn
Sep 30, 2024 14.52 Mn
Jun 30, 2024 13.69 Mn
Mar 31, 2024 15.17 Mn
Dec 31, 2023 41.26 Mn
Mar 31, 2023 48.30 Mn
Dec 31, 2022 40.84 Mn
Sep 30, 2022 16.50 Mn
Jun 30, 2022 9.09 Mn
Mar 31, 2022 10.10 Mn
Dec 31, 2021 8.97 Mn
Sep 30, 2021 6.60 Mn
Jun 30, 2021 5.27 Mn
Mar 31, 2021 3.93 Mn
Dec 31, 2020 5.42 Mn
Sep 30, 2020 4.85 Mn
Jun 30, 2020 5.15 Mn
Dec 31, 2019 3.30 Mn
API Access

Serina Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SER&period=max&api_key=YOUR_API_KEY